Pluri Inc.
Pluri Inc. (PLUR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PLUR · as of Jun 9, 2026
Key Statistics
Explore Pluri Inc. Data
plur stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
plur competitorsPLUR
ANTX
BOLD
IBIO
INTS
ITRMStock Performance
Full HistoryAbout Pluri Inc.
Pluri Inc. a biotechnology company established in 2001 and headquartered in Haifa, Israel, specializes in developing innovative placenta-derived cell therapies. Its core mission is to tackle a range …
what is pluri inc. · plur stock overview · pluri inc. company profile · who is pluri inc. ceo · plur NASDAQ · pluri inc. headquarters · pluri inc. business segments
About Stock Overview & Key Data
Pluri Inc. (PLUR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 30, 2003. As of the latest trading session, PLUR stock price is $2.31, with a market capitalization of $20.8M. The stock has returned -47.38% over the past 12 months and -22.74% year-to-date.
In fiscal year 2025, Pluri Inc. reported revenue of $1.3M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Pluri Inc. (PLUR) stock price is $2.31. The stock is traded on NASDAQ under the ticker symbol PLUR. The 52-week range is $2.22 – $5.96.